Activated T cells in HTLV-I-associated myelopathy: autologous mixed lymphocyte reaction

S Minato1, Y Itoyama, N Fujii

  • 1Department of Neurology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Annals of Neurology
|September 1, 1989
PubMed

Insights

In human T-cell lymphotropic virus type I-associated myelopathy, autologous mixed lymphocyte reactions were elevated but did not explain increased lymphocyte proliferation. This suggests other mechanisms drive the heightened immune cell activity in this condition.

Area of Science:

  • Immunology
  • Virology
  • Neurology

Background:

  • Human T-cell lymphotropic virus type I (HTLV-I) infection is linked to HTLV-I-associated myelopathy (HAM).
  • Patients with HAM exhibit increased spontaneous proliferation of peripheral blood lymphocytes.
  • The role of autologous mixed lymphocyte reaction (AMLR) in this phenomenon is unclear.

Purpose of the Study:

  • To investigate the contribution of AMLR to the increased spontaneous lymphocyte proliferation observed in HAM patients.
  • To differentiate the cellular components involved in AMLR in HAM.

Main Methods:

  • Assessed AMLR proliferative responses in 9 HAM patients and healthy controls.
  • Depleted non-T-cell fractions from AMLR cultures to evaluate their impact on proliferation.

Main Results:

  • AMLR proliferative responses were significantly higher in HAM patients (34,205 cpm) compared to controls (18,695 cpm).
  • Depletion of non-T-cells suppressed AMLR in controls but did not affect proliferation in HAM patients.
  • This indicates the increased proliferation in HAM is T-cell independent of AMLR.

Conclusions:

  • The elevated AMLR in HAM patients does not account for their increased spontaneous lymphocyte proliferation.
  • The mechanisms driving heightened lymphocyte proliferation in HAM likely involve pathways independent of AMLR.